investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Development of Novel Agents Active against Hepatitis B Virus
Hiroaki Mitsuya
5 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Hiroyuki Hayakawa
Yamasa Corporation (Japan)
Chiba, Japan
Yasuhito Tanaka
Nagoya City University
Nagoya, Japan
Masayuki Amano
Kumamoto University
Kumamoto, Japan
Manabu Aoki
Kumamoto University
Kumamoto, Japan
Hiromi Ogata-Aoki
Kumamoto University
Kumamoto, Japan
Hiroaki Mitsuya
National Cancer Institute (NIH)
Rockville, United States
Related projects
John Tavis
HBV Drug Development
Liver and intrahepatic bile ducts
Pathology
Xin Wei Wang
Molecular signatures for liver cancer diagnosis and treatment stratification
Liver and intrahepatic bile ducts
Pathology
Shelly Chi-Loo Lu
Prohibitin 1 in Liver Injury and Cancer
Liver and intrahepatic bile ducts
Pathology
Stephen V Desiderio
Temporal and Spatial Control of V(D)J Recombination
Leukaemia
Pathology
Cheryl Winkler
Identification of Genetic Factors Associated with Infectious Diseases
Liver and intrahepatic bile ducts
Pathology
Lewis R Roberts
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma
Liver and intrahepatic bile ducts
Pathology
Gregory F Oxenkrug
Depression, insulin resistance and xanthurenic acid in hepatitis C virus patients
Liver and intrahepatic bile ducts
Pathology
Robert F Schwabe
Hepatic Stellate Cells and Liver Cancer
Liver and intrahepatic bile ducts
Pathology
Katherine L B Borden
Molecular Mechanisms of eIF4E mediated transformation
Leukaemia
Pathology
